You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
以嶺藥業(002603.SZ)澄清連花清瘟研發過程只有15天報道與事實不符
阿思達克 04-20 12:29
以嶺藥業(002603.SZ)於深交所互動易平臺澄清,有關「連花清瘟研發過程只有15天」的報道與事實不符,強調連花清瘟新藥研發過程是國家在特殊疫情時期快速審批和研發人員共同努力的結果,符合國家藥品監督部門新藥研發程序。 此外,公司指出,目前正全力以赴做好科研工作,保質保量生產,保障市場供應,爲疫情防控貢獻力量。公司會持續跟蹤事態發展情況,對於一些詆譭公司、發佈不實信息的行爲,公司已保留證據並向相關部門報案,將通過法律手段維護自身合法權益。 以嶺藥業半日跌7.9%,報29.85元人民幣,成交8,920萬股,涉資逾27億元人民幣。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account